Badia-Aguarón, T, Royuela-Colomer, E, Pera-Guardiola, V, Vergés-Balasch, P, Cebolla, A, Luciano, JV, Soler, J, Feliu-Soler, A, Miguel, AH. Combining mindfulness and cognitive training in children with attention deficit hyperactivity disorder: study protocol of a pilot randomized controlled trial (the NeuroMind study). Frontiers in Psychology. 2024; 15DOI:10.3389/fpsyg.2024.1291198. PMID:38384348. IF:2.900(Q1/3D).

Feliu-Soler, A, Royuela-Colomer, E, Navarrete, J, Jorgensen, NN, Mariño, M, Demarzo, M, Soler, J, García-Campayo, J, Montero-Marín, J, Luciano, JV. Assessing the Impact of the Way of Saint James on Psychological Distress and Subjective Well-being: The Ultreya Study. Journal of Happiness Studies. 2024; 25(7)DOI:10.1007/s10902-024-00820-0. PMID:. IF:3.300(Q1/1D).

Janssen, O, Jansen, WJ, Vos, SJB, Boada, M, Parnetti, L, Gabryelewicz, T, Fladby, T, Molinuevo, JL, Villeneuve, S, Hort, J, Epelbaum, S, Lleo, A, Engelborghs, S, van der Flier, WM, Landau, S, Popp, J, Wallin, A, Scheltens, P, Rikkert, MO, Snyder, PJ, Rowe, C, Chetelat, G, Ruiz, A, Marquie, M, Chipi, E, Wolfsgruber, S, Heneka, M, Boecker, H, Peters, O, Jarholm, J, Rami, L, Tort-Merino, A, Binette, AP, Poirier, J, Rosa-Neto, P, Cerman, J, Dubois, B, Teichmann, M, Alcolea, D, Fortea, J, Sanchez-Saudinos, MB, Ebenau, J, Pocnet, C, Eckerstrom, M, Thompson, L, Villemagne, V, Buckley, R, Burnham, S, Delarue, M, Freund-Levi, Y, Wallin, AK, Ramakers, I, Tsolaki, M, Soininen, H, Hampel, H, Spiru, L, Tijms, B, Ossenkoppele, R, Verhey, FRJ, Jessen, F, Visser, PJ. Characteristics of subjective cognitive decline associated with amyloid positivity. ALZHEIMERS & DEMENTIA. 2022; 18(10)DOI:10.1002/alz.12512. PMID:34877782. IF:14.000(Q1/1D).

Hillerstrom, H, Fisher, R, Janicki, MP, Chicoine, B, Christian, BT, Esbensen, A, Esralew, L, Fortea, J, Hartley, S, Hassenstab, J, Keller, SM, Krinsky-McHale, S, Lai, FRC, Levin, J, Mccarron, M, Mcdade, E, Rebillat, AS, Rosas, HD, Silverman, W, Strydom, A, Zaman, SH, Zetterberg, H. Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome. ALZHEIMERS & DEMENTIA. 2024; 20(5)DOI:10.1002/alz.13778. PMID:38480678. IF:11.100(Q1/1D).